Skip to main content
SpringerLink
Log in

Evaluating the expression level of Survivin gene in different groups of B-cell acute lymphoblastic leukemia patients of Iran

  • Original Article
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Survivin is one of the major members of Inhibitory Apoptotic Proteins (IAP) family. The functional anti-apoptotic and regulatory role of Survivin in the cell cycle had made it as an interesting candidate for tumor studies. Acute lymphoblastic leukemia is one of the most common malignancies of children that accounts for 30% of all the childhood malignancies. The purpose of this study was to investigate the prognostic importance of Survivin level in B-cell acute lymphoblastic leukemia patients of Iran in four different steps of disease in order to follow up its impact on various treatment ways, the development of the disease, and the response to treatment in the patients. The expression level of Survivin was evaluated in 85 patients with B-cell acute lymphoblastic leukemia and 85 healthy controls using Quantitative Real-Time Polymerase Chain Reaction. Also, western blot analysis was done to confirm the results. Based on our findings, the expression of Survivin showed a significant up-regulation in patients compared to controls. Therefore, a correlation between Survivin expression and the development pattern of B-cell acute lymphoblastic leukemia with a strong diagnostic efficiency (AUC-ROC, 0.8562) was observed. Therefore, it can be introduced as a potential marker for prognosis B-cell Acute Lymphoblastic Leukemia in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ribera J-M, Oriol A (2009) Acute lymphoblastic leukemia in adolescents and young adults. Hematol Oncol Clin North Am 23(5):1033–1042

    Article  PubMed  Google Scholar 

  2. Inaba H, Greaves M, Mullighan CG (2013) Acute lymphoblastic leukaemia. The Lancet 381(9881):1943–1955

    Article  Google Scholar 

  3. Bhojwani D, Kang H, Moskowitz NP, Min D-J, Lee H, Potter JW, Davidson G, Willman CL, Borowitz MJ, Belitskaya-Levy I (2006) Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children’s Oncology Group study. Blood 108(2):711–717

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Altieri DC (2003) Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3(1):46

    Article  CAS  PubMed  Google Scholar 

  5. Altieri DC (2003) Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22(53):8581

    Article  CAS  PubMed  Google Scholar 

  6. Altieri DC (2003) Survivin and apoptosis control. Adv Cancer Res 88:31–52

    Article  CAS  PubMed  Google Scholar 

  7. Ambrosini G, Adida C, Sirugo G, Altieri DC (1998) Induction of apoptosis and inhibition of cell proliferation bysurvivin gene targeting. J Biol Chem 273(18):11177–11182

    Article  CAS  PubMed  Google Scholar 

  8. Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3(8):917–921

    Article  CAS  PubMed  Google Scholar 

  9. Monzó M, Rosell R, Felip E, Astudillo J, Sánchez JJ, Maestre J, Martín C, Font A, Barnadas A, Abad A (1999) A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non–small-cell lung cancers. J Clin Oncol 17(7):2100–2100

    Article  PubMed  Google Scholar 

  10. Song Z, Yao X, Wu M (2003) Direct interaction between survivin and Smac is essential for the anti-apoptotic activity of survivin during Taxol-induced apoptosis. J Biol Chem. https://doi.org/10.1074/jbc.M300957200

    Article  PubMed  PubMed Central  Google Scholar 

  11. Yamamoto T, Tanigawa N (2001) The role of survivin as a new target of diagnosis and treatment in human cancer. Med Electron Microsc 34(4):207–212

    Article  CAS  PubMed  Google Scholar 

  12. Adida C, Berrebi D, Peuchmaur M, Reyes-Mugica M, Altieri DC (1998) Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. The Lancet 351(9106):882–883

    Article  CAS  Google Scholar 

  13. Troeger A, Siepermann M, Escherich G, Meisel R, Willers R, Gudowius S, Moritz T, Laws H-J, Hanenberg H, Goebel U (2007) Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia. Haematologica 92(8):1043–1050

    Article  CAS  PubMed  Google Scholar 

  14. Asanuma K, Kobayashi D, Furuya D, Tsuji N, Yagihashi A, Watanabe N (2002) A role for survivin in radioresistance of pancreatic cancer cells. Jpn J Cancer Res 93(9):1057–1062

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Mendez-David I, El-Ali Z, Hen R, Falissard B, Corruble E, Gardier AM, Kerdine-Romer S, David DJ (2013) A method for biomarker measurements in peripheral blood mononuclear cells isolated from anxious and depressed mice: β-arrestin 1 protein levels in depression and treatment. Front Pharmacol 4:124

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Goyal L (2001) Cell death inhibition: keeping caspases in check. Cell 104(6):805–808

    Article  CAS  PubMed  Google Scholar 

  17. Terwilliger T, Abdul-Hay M (2017) Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J 7(6):e577

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Tracey L, Pérez-Rosado A, Artiga MJ, Camacho FI, Rodríguez A, Martínez N, Ruiz-Ballesteros E, Mollejo M, Martinez B, Cuadros M (2005) Expression of the NF-κB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively. J Pathol 206(2):123–134

    Article  CAS  PubMed  Google Scholar 

  19. Karanikas V, Tsochas S, Boukas K, Kerenidi T, Nakou M, Dahabreh J, Poularakis T, Gourgoulianis KI, Germenis AE (2008) Co-expression patterns of tumor-associated antigen genes by non-small cell lung carcinomas: Implications for immunotherapy. Cancer Biol Ther 7(3):345–352

    Article  CAS  PubMed  Google Scholar 

  20. González-González R, Molina-Frechero N, Damian-Matsumura P, Salazar-Rodriguez S, Bologna-Molina R (2015) Immunohistochemical expression of Survivin and its relationship with cell apoptosis and proliferation in ameloblastomas. Dis Markers. https://doi.org/10.1155/2015/301781

    Article  PubMed  PubMed Central  Google Scholar 

  21. Esh AM, Atfy M, Azizi NA, El Naggar MM, Khalil EE, Sherief L (2011) Prognostic significance of survivin in pediatric acute lymphoblastic leukemia. Indian J Hematol Blood Transfus 27(1):18–25

    Article  PubMed  PubMed Central  Google Scholar 

  22. Holleman A, den Boer ML, de Menezes RX, Cheok MH, Cheng C, Kazemier KM, Janka-Schaub GE, Göbel U, Graubner UB, Evans WE (2006) The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia. Blood 107(2):769–776

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Hayashibara T, Yamada Y, Nakayama S, Harasawa H, Tsuruda K, Sugahara K, Miyanishi T, Kamihira S, Tomonaga M, Maita T (2002) Resveratrol induces downregulation in survivin expression and apoptosis in HTLV-1-infected cell lines: a prospective agent for adult T cell leukemia chemotherapy. Nutr Cancer 44(2):193–201

    Article  PubMed  Google Scholar 

  24. Carter BZ, Wang R-Y, Schober WD, Milella M, Chism D, Andreeff M (2003) Targeting survivin expression induces cell proliferation defect and SubsequentCell death involving mitochondrial pathway in myeloid leukemic cells. Cell Cycle 2(5):486–491

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Genetics, Faculty of Science, Science and Research Branch, Islamic Azad University, Tehran, Iran

    Mahan Mohammadi

  2. Genetic Division, Department of Biology, Faculty of Sciences, University of Isfahan, Isfahan, Iran

    Farzane Amirmahani

  3. Department of Plant Breeding, Yazd Branch, Islamic Azad University, Yazd, Iran

    Kiarash Jamshidi Goharrizi & Rambod Pakzad

  4. Department of Urology, Shahid Beheshti University of Medical Science, Tehran, Iran

    Hossein Dolat

Authors
  1. Mahan Mohammadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Farzane Amirmahani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kiarash Jamshidi Goharrizi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rambod Pakzad
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hossein Dolat
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Mahan Mohammadi or Farzane Amirmahani.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This study is approved by Islamic Azad university of Ahar (Tabriz, Iran) review board and also the ethics committee of Children Medical Research and Training Hospital (Tabriz, Iran). A written consent form was obtained from each patient ҆s patent according to the Declaration of Helsinki.

Informed consent

A written informed consent was also obtained from parents of healthy control subjects.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mohammadi, M., Amirmahani, F., Goharrizi, K.J. et al. Evaluating the expression level of Survivin gene in different groups of B-cell acute lymphoblastic leukemia patients of Iran. Mol Biol Rep 46, 2679–2684 (2019). https://doi.org/10.1007/s11033-019-04703-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-019-04703-z

Keywords

Search

Navigation